€22.79
-0.21 (-0.91%)
EUR · as of 2026-08-17 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where UPM.HE is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
3 interventional
Held by 0 tracked-famous managers · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Post-market Clinical Follow-up Study for a CE Marked Wound Care Product (FibDex®)NCT05666999Wound healingRandomized · Triple-masked · Other | Not applicable | Terminatedsponsor's stated reason: UPM Kymmene Oyj announced on April 2, 2025, the closure of Biomedicals business. As a result, FibDex manufacturing and sales will discontinue. The premature termination is due to business decision, not related to any safety concerns of FibDex. | Device: FibDex®, Suprathel, Aquacel Foam | Skin Transplantation | 18 | 2025-04-30actual | 2025-08-15 |
| An Investigation of Performance and Safety of the Wound Dressing FibDex in Patients With Superficial Dermal BurnsNCT05629091Non-inferiority of FibDex® compared to Epicitehydro in terms of time to clinical wound healing (days) defined as no need of any dressing (inner or outer)Randomized · Open-label · Treatment | Not applicable | Terminatedsponsor's stated reason: UPM Kymmene Oyj announced on April 2, 2025, the closure of Biomedicals business. As a result, FibDex manufacturing and sales will discontinue. The premature termination is due to business decision, not related to any safety concerns of FibDex. | Device: FibDex, Epicite hydro, Epiprotect | Burns | 7 | 2025-04-10actual | 2025-08-15 |
| NFC Dressing for Skin Graft Donor SitesNCT03980600Wound healing timeOpen-label · Treatment | Not applicable | Completed | Device: FibDex wound dressing, NFC wound dressing Types 1-3, Suprathel (comparator) | Skin Transplantation | 33 | 2018-01-08actual | 2019-06-10 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19